Posted on 21 October 2014.
The Institute of Medicine (IOM) today announced the names of 70 new members and 10 foreign associates during its 44th annual meeting. Election to the IOM is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.
“It is with great enthusiasm that we welcome our esteemed colleagues to the Institute of Medicine,” said IOM President Victor J. Dzau. ”These leaders’ tremendous achievements have contributed significantly to advancing health and medicine. The expertise and knowledge they bring to the IOM will encourage and enhance its success.”
New members are elected by current active members through a selective process that recognizes individuals who have made major contributions to the advancement of the medical sciences, health care, and public health. A diversity of talent among IOM’s membership is assured by the Institute’s charter, which stipulates that at least one-quarter of the membership is selected from outside the health professions, for example, from such fields as the law, engineering, social sciences, and the humanities. The newly elected members raise IOM’s total active membership to 1,798 and the number of foreign associates to 128. With an additional 86 members holding emeritus status, IOM’s total membership is 2,012.
The Institute of Medicine is unique in its structure as both an honorific membership organization and an advisory organization. Established in 1970 by the National Academy of Sciences, IOM has become recognized as a national resource for independent, scientifically informed analysis and recommendations on health issues. With their election, members make a commitment to volunteer their service on IOM committees, boards, and other activities. Projects during the past year include studies on meeting the needs of those nearing the end of life, determining what is known about and how to reduce sport-related concussions in youth athletes, analyzing the treatment of post-traumatic stress disorder in military and veteran populations, enhancing governance and accountability in graduate medical education, and examining long-term health effects of blast exposures.
Newly elected members of the Institute of Medicine are:
Goncalo Rocha Abecasis, Ph.D., professor and chair, department of biostatistics, University of Michigan School of Public Health, Ann Arbor
Rafi Ahmed, Ph.D., professor, department of microbiology and immunology; director, Emory Vaccine Center; and Georgia Research Alliance Eminent Scholar, Emory University School of Medicine, Atlanta
Robert A. Aronowitz, M.D., professor and chair, department of history and sociology of science, and professor of family medicine and community health, University of Pennsylvania, Philadelphia
Ben A. Barres, M.D., Ph.D., professor of neurobiology, developmental biology, and neurology, Stanford University School of Medicine, Stanford, Calif.
Jose Baselga, M.D., Ph.D., physician-in-chief and chief medical officer, Memorial Sloan Kettering Cancer Center, New York City
Chris Beyrer, M.D., M.P.H., professor of epidemiology, international health, and health, behavior, and society, Johns Hopkins Bloomberg School of Public Health, Baltimore
Walter F. Boron, M.D., Ph.D., Myers/Scarpa Professor, and chair, department of physiology and biophysics, Case Western Reserve University, Cleveland
Carol R. Bradford, M.D., Charles J. Krause, M.D. Collegiate Professor, and chair, department of otolaryngology-head and neck surgery, University of Michigan Health System, Ann Arbor
Jeffrey Brenner, M.D., medical director, Urban Health Institute at Cooper University Healthcare, and executive director, Camden Coalition of Healthcare Providers, Camden, N.J.
Nancy J. Brown, M.D., Hugh Jackson Morgan Professor of Medicine and Pharmacology, and chair and physician-in-chief, department of medicine, Vanderbilt University, Nashville, Tenn.
Lewis Clayton Cantley, Ph.D., director, Sandra and Edward Meyer Cancer Center, Weill Cornell Medical College/New York-Presbyterian Hospital, New York City
Arturo Casadevall, M.D., Ph.D., chairman, department of microbiology and immunology, Albert Einstein College of Medicine, New York City
Elliot L. Chaikof, M.D., Ph.D., Johnson and Johnson Professor of Surgery, Harvard Medical School; chairman, Roberta and Stephen R. Weiner Department of Surgery; and surgeon-in-chief, Beth Israel Deaconess Medical Center, Boston
E. Antonio Chiocca, M.D., Ph.D., FAANS, neurosurgeon-in-chief and chairman, department of neurosurgery, and co-director, Institute for the Neurosciences, Brigham and Women’s/Faulkner Hospital; surgical director, Center for Neuro-oncology, Dana-Farber Cancer Institute; and Harvey W. Cushing Professor of Neurosurgery, Harvard Medical School, Boston
James J. Cimino, M.D., chief, Laboratory for Informatics Development, NIH Clinical Center and National Library of Medicine, Bethesda, Md.
Patrick Conway, M.D., M.Sc., chief medical officer and deputy administrator for innovation and quality, and director, Center for Clinical Standards and Quality, Centers for Medicare & Medicaid Services, Baltimore
James E. Crowe Jr., M.D., director, Vanderbilt Vaccine Center, and Ann Scott Carell Chair Professor, departments of pediatrics, pathology, microbiology, and immunology, Vanderbilt University Medical Center, Nashville, Tenn.
Pamela B. Davis, M.D., Ph.D., dean and senior vice president for medical affairs, Case Western Reserve University, Cleveland
Linda C. Degutis, Dr.P.H., M.S.N., consultant, Degutis Consulting, Atlanta
Joseph M. DeSimone, Ph.D., Chancellor’s Eminent Professor of Chemistry and William R. Kenan Jr. Distinguished Professor of Chemistry, departments of chemistry and pharmacology, University of North Carolina and North Carolina State University, Chapel Hill
Jennifer E. DeVoe, M.D., D.Phil., associate professor, department of family medicine, Oregon Health and Science University, Portland
Daniel B. Drachman, M.D., professor of neurology and neuroscience, and W.W. Smith Charitable Trust Professor of Neuroimmunology, Johns Hopkins School of Medicine, Baltimore
James Economou, M.D., Ph.D., vice chancellor for research and Beaumont Professor of Surgery, University of California, Los Angeles
Eva L. Feldman, M.D., Ph.D., Russell N. DeJong Professor of Neurology, and director, A. Alfred Taubman Medical Research Institute, University of Michigan Health System, Ann Arbor
A. Mark Fendrick, M.D., professor, department of internal medicine, School of Medicine, and professor, department of health management and policy, School of Public Health, University of Michigan, Ann Arbor
Stephanie Lida Ferguson, Ph.D., RN, FAAN, director, International Council of Nurses Leadership for Change Programme, Amherst, Va.
Todd R. Golub, M.D., investigator, Howard Hughes Medical Institute; chief scientific officer, Broad Institute of Harvard and MIT; and Charles A. Dana Investigator, Dana-Farber Cancer Institute, Cambridge, Mass.
Eric P. Goosby, M.D., professor of medicine, and director, Institute of Global Health Delivery and Diplomacy, UCSF School of Medicine, Global Health Sciences, San Francisco
Mark A. Hall, J.D., Fred and Elizabeth Turnage Professor of Law and Public Health, Wake Forest University, Winston-Salem, N.C.
Margaret Heitkemper, Ph.D., RN, FAAN, professor and chair of biobehavioral nursing, biobehavioral nursing and health systems, School of Nursing, University of Washington, Seattle
James O. Hill, Ph.D., Anschutz Professor, departments of pediatrics and medicine, and director, Anschutz Health and Wellness Center, University of Colorado, Aurora
Bradley T. Hyman, M.D., Ph.D., John B. Penney Jr. Professor of Neurology, Harvard Medical School, and Alzheimer’s Unit Director, MassGeneral Institute for Neurodegenerative Disease, Charlestown, Mass.
George Isham, M.D., M.S., senior adviser, HealthPartners, and senior fellow, HealthPartners Institute for Education & Research, Minneapolis
Julie A. Johnson, Pharm.D., distinguished professor and dean, College of Pharmacy, University of Florida, Gainesville
Paula A. Johnson, M.D., M.P.H., professor of medicine, Harvard Medical School; professor of epidemiology, Harvard School of Public Health; executive director, Connors Center for Women’s Health and Gender Biology; and chief, division of women’s health, Brigham and Women’s Hospital, Boston
Gerald F. Joyce, M.D., Ph.D., professor, department of chemistry, The Scripps Research Institute, La Jolla, Calif.
Gerard Karsenty, M.D., Ph.D., Paul A. Mark Professor and Chairman, department of genetics and development, Columbia University, New York City
Mitchell H. Katz, M.D., director, department of health services, County of Los Angeles
Carol Keehan, DC, president and chief executive officer, Catholic Health Association of the United States, Washington, D.C.
Sara Kenkare-Mitra, Ph.D., senior vice president, Development Sciences Genentech Research and Early Development, Hoffmann La-Roche, South San Francisco
Paul A. Khavari, M.D., Ph.D., professor and chairman, department of dermatology, Stanford University, Stanford, Calif.
Mary E. Klotman, M.D., R.J. Reynolds Professor, School of Medicine, and chair, department of medicine, Duke University Medical Center, Durham, N.C.
Brian K. Kobilka, M.D., professor of molecular and cellular physiology, Stanford University School of Medicine, Stanford, Calif.
Richard G. Kronick, Ph.D., director, Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services, Rockville, Md.
Christian P. Larsen, M.D., D.Phil., dean, School of Medicine, Emory University, Atlanta
Steven H. Lipstein, MHA, president and chief executive officer, BJC HealthCare, St. Louis
Catherine Lord, Ph.D., director, Center for Autism and the Developing Brain; Dewitt Wallace Senior Scholar; and professor, psychology and pediatrics in psychiatry, Weill Cornell Medical College/New York-Presbyterian Hospital, White Plains, N.Y.
Guillermina (Gigi) Lozano, Ph.D., professor and chair, department of genetics, The University of Texas MD Anderson Cancer Center, Houston
Edward Wilson Merrill, D.Sc., C.P. Dubbs Professor of Chemical Engineering, emeritus, Massachusetts Institute of Technology, Belmont
Kelle Harbert Moley, M.D., James P. Crane Professor of Obstetrics and Gynocology, and vice chair and chief, division of basic science research, Washington University School of Medicine, St. Louis
Susan A. Murphy, Ph.D., H.E. Robbins Distinguished University Professor of Statistics; professor of psychiatry; and research professor, Institute for Social Research, University of Michigan, Ann Arbor
Harry T. Orr, Ph.D., director, Institute of Translational Neuroscience, and professor, department of laboratory medicine and pathology, University of Minnesota, Minneapolis
John Joseph O’Shea Jr., M.D., scientific director, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Md.
David R. Piwnica-Worms, M.D., Ph.D., professor and chair, department of cancer systems imaging, and
deputy head, division of diagnostic imaging, The University of Texas MD Anderson Cancer Center, Houston
Kathleen Marie Potempa, Ph.D., RN, FAAN, dean and professor, University of Michigan School of Nursing, Ann Arbor
Meredith Rosenthal, Ph.D., professor of health economics and policy, Harvard School of Public Health, Boston
Bryan L. Roth, M.D., Ph.D., Michael J. Hooker Distinguished Professor, department of pharmacology, University of North Carolina Medical School, Chapel Hill
W. Mark Saltzman, Ph.D., Goizueta Professor of Biomedical Engineering, Yale University, New Haven, Conn.
Randy Wayne Schekman, Ph.D., investigator, Howard Hughes Medical Institute; and professor of cell and developmental biology, University of California, Berkeley
Martin Jose Sepulveda, M.D., M.P.H., IBM Fellow, and vice president, health systems and policy research, IBM Research, IBM Corp., Somers, N.Y.
Michael N. Shadlen, M.D., Ph.D., investigator, Howard Hughes Medical Institute; and professor, department of neuroscience, Zuckerman Mind Brain Behavior Institute, Kavli Institute for Brain Science, Columbia University, New York City
Joshua M. Sharfstein, M.D., secretary, Maryland Department of Health and Mental Hygiene, Baltimore
Margaret A. Shipp, M.D., chief, division of hematologic neoplasia, Dana-Farber Cancer Institute, Boston
Bruce M. Spiegelman, Ph.D., Stanley J. Korsmeyer Professor of Cell Biology and Medicine, Dana-Farber Cancer Institute, Harvard Medical School, Boston
Deepak Srivastava, M.D., director, Gladstone Institute of Cardiovascular Disease, and professor, University of California, San Francisco
Robyn Stone, Dr.P.H., senior vice president for research, Center for Applied Research, LeadingAge, Washington, D.C.
Joseph S. Takahashi, Ph.D., investigator, Howard Hughes Medical Institute; and professor and chair, department of neuroscience, and Loyd B. Sands Distinguished Chair in Neuroscience, University of Texas Southwestern Medical Center, Dallas
Dan Theodorescu, M.D., Ph.D., Paul A. Bunn Cancer Research Chair, professor of surgery and pharmacology, and director, University of Colorado Comprehensive Cancer Center, University of Colorado, Denver
Ronald David Vale, Ph.D., investigator, Howard Hughes Medical Institute; and professor of cellular and molecular pharmacology, University of California, San Francisco
Gordana Vunjak-Novakovic, Ph.D., Mikati Foundation Professor of Biomedical Engineering; professor of medical sciences; and director, Laboratory for Stem Cells and Tissue Engineering, Columbia University, New York City
Newly elected foreign associates are:
Quarraisha Abdool Karim, Ph.D., professor, Centre for the AIDS Programme of Research in South Africa,
University of KwaZulu-Natal, Durban, South Africa
Pascale Cossart, Ph.D., professor and head of Bacteria-Cell Interactions Unit, Institut Pasteur, Paris
Christian J. Herold, M.D., professor, department of biomedical imaging and image-guided therapy, Vienna General Hospital, Medical University of Vienna, Vienna
Yang Ke, M.S., professor; executive vice president, Peking University; and executive vice president; Peking University Health Science Center, Beijing
Jianan Li, M.D., professor and doctor, Rehabilitation Medicine Center, First Affiliated Hospital of Nanjing Medical University, Nanjing, China
Denis Mukwege, M.D., medical director of General Referral Hospital, obstetrics and gynecology, Panzi Hospital, Bukavu, Democratic Republic of the Congo
Michael Vivian Sefton, Ph.D., university professor, department of chemical engineering and applied chemistry, Institute of Biomaterials and Biomedical Engineering, University of Toronto, Toronto
Irma Thesleff, D.D.S., Ph.D., professor and research director, Developmental Biology Program, Institute of Biotechnology-University of Helsinki, Helsinki
Sheila Dinotshe Tlou, Ph.D., RN, regional director for Eastern and Southern Africa, UNAIDS, Johannesburg
Charlotte Watts, Ph.D., professor, social and mathematical epidemiology, department of global health and development, London School of Hygiene and Tropical Medicine, London